Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19875126rdf:typepubmed:Citationlld:pubmed
pubmed-article:19875126lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C0015733lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C0872252lld:lifeskim
pubmed-article:19875126lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:19875126pubmed:issue19lld:pubmed
pubmed-article:19875126pubmed:dateCreated2010-4-19lld:pubmed
pubmed-article:19875126pubmed:abstractTextTumor related products shed into the feces offer a potential source of biomarkers for the detection of colorectal cancer (CRC). Using SDS-PAGE followed by nanoflow reversed-phased LC-MS/MS to analyse fecal samples from Apc(Min/+) mice (that develop spontaneous multiple intestinal neoplasia with age) we have identified 336 proteins (115 proteins of murine origin, 201 from fecal bacteria, 18 associated with food intake and 2 of apparent parasitic origin). 75% of the murine proteins identified in this study are predicted to be extracellular or associated with the cell plasma membrane. Of these proteins, a number of the murine homologues of colorectal cancer associated proteins (CCAP) such as hemoglobin, haptoglobin, hemopexin, alpha-2-macroglobulin and cadherin-17 have been identified, demonstrating the potential of fecal proteomics for detecting potential biomarkers and paving the way for subsequent MS/MS based biomarker studies on similar human samples.lld:pubmed
pubmed-article:19875126pubmed:languageenglld:pubmed
pubmed-article:19875126pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19875126pubmed:citationSubsetIMlld:pubmed
pubmed-article:19875126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19875126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19875126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19875126pubmed:statusMEDLINElld:pubmed
pubmed-article:19875126pubmed:monthMaylld:pubmed
pubmed-article:19875126pubmed:issn1873-3778lld:pubmed
pubmed-article:19875126pubmed:authorpubmed-author:NiceEdouard...lld:pubmed
pubmed-article:19875126pubmed:authorpubmed-author:BurgessAntony...lld:pubmed
pubmed-article:19875126pubmed:authorpubmed-author:RothackerJuli...lld:pubmed
pubmed-article:19875126pubmed:authorpubmed-author:AngChing-Seng...lld:pubmed
pubmed-article:19875126pubmed:authorpubmed-author:PatsiourasHea...lld:pubmed
pubmed-article:19875126pubmed:copyrightInfoCopyright (c) 2009 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:19875126pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19875126pubmed:day7lld:pubmed
pubmed-article:19875126pubmed:volume1217lld:pubmed
pubmed-article:19875126pubmed:ownerNLMlld:pubmed
pubmed-article:19875126pubmed:authorsCompleteYlld:pubmed
pubmed-article:19875126pubmed:pagination3330-40lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:meshHeadingpubmed-meshheading:19875126...lld:pubmed
pubmed-article:19875126pubmed:year2010lld:pubmed
pubmed-article:19875126pubmed:articleTitleMurine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.lld:pubmed
pubmed-article:19875126pubmed:affiliationLudwig Institute for Cancer Research, Melbourne Tumour Biology Branch, PO Box 2008, Royal Melbourne Hospital, Australia.lld:pubmed
pubmed-article:19875126pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19875126pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed